In a patient with type 2 diabetes who is taking prednisone 15 mg in the morning and 5 mg in the evening, and insulin glargine (Lantus) 10 U in the morning and 6 U in the evening with a 1 U:12 g carbohydrate ratio, if the evening prednisone is discontinued, how should the basal insulin dose and insulin‑to‑carbohydrate ratio be adjusted?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 7, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Insulin Adjustment After Discontinuing Evening Prednisone

Reduce the evening Lantus dose by approximately 20-30% (from 6 units to 4-5 units) when discontinuing the 5 mg evening prednisone, while maintaining the morning Lantus dose at 10 units initially. The insulin-to-carbohydrate ratio can remain at 1:12 initially but should be monitored closely and adjusted based on blood glucose patterns.

Rationale for Dose Reduction

Prednisone causes dose-dependent insulin resistance, with effects most pronounced during the hours following administration 1, 2. When you discontinue the evening prednisone dose:

  • The evening/overnight insulin requirement will decrease significantly because the glucocorticoid-induced insulin resistance that was present during those hours will resolve
  • Research demonstrates that even low-dose prednisone (10-25 mg) causes substantial insulin resistance in a dose-dependent manner 2
  • The morning prednisone (15 mg) will continue to cause daytime hyperglycemia, so morning basal insulin requirements should remain relatively stable

Specific Dosing Algorithm

Basal Insulin (Lantus) Adjustment:

Evening dose:

  • Current: 6 units
  • New dose: 4-5 units (approximately 20-30% reduction)
  • This follows the general principle that when reducing glucocorticoid exposure, insulin requirements decrease proportionally 3

Morning dose:

  • Maintain at 10 units initially
  • The 15 mg morning prednisone continues, so morning basal requirements remain unchanged

Insulin-to-Carbohydrate Ratio:

  • Keep at 1:12 initially for all meals
  • The carb ratio primarily affects mealtime coverage, and since morning prednisone continues, daytime insulin sensitivity remains similar
  • Monitor post-meal glucose patterns, particularly at dinner and overnight

Monitoring and Titration Strategy

Critical monitoring periods:

  • Evening through overnight (when the discontinued prednisone previously caused hyperglycemia)
  • Expect lower glucose readings in this timeframe
  • Risk of nocturnal hypoglycemia is the primary concern 4

Adjustment protocol 3:

  • Check fasting blood glucose daily
  • If fasting glucose <70 mg/dL or nocturnal hypoglycemia occurs: reduce evening Lantus by additional 10-20%
  • If fasting glucose remains >130 mg/dL after 3 days: increase evening Lantus by 1-2 units every 3 days
  • Adjust carb ratio if consistent post-meal hyperglycemia or hypoglycemia develops (increase ratio to 1:15 if hypoglycemia, decrease to 1:10 if hyperglycemia)

Important Caveats

Timing considerations:

  • Lantus should continue to be dosed at the same times daily (morning and evening) 4
  • The pharmacodynamics of Lantus differ based on administration time, with greater activity in the 12 hours following injection 5

Common pitfall to avoid:

  • Do not reduce both morning and evening Lantus doses simultaneously when only the evening prednisone is discontinued
  • The morning prednisone (15 mg) continues to drive daytime insulin resistance, so morning basal needs persist

If further prednisone tapering occurs:

  • When the morning prednisone dose is eventually reduced or discontinued, expect to reduce the morning Lantus dose by approximately 20-30% per 5 mg prednisone reduction
  • Consider switching to a single daily Lantus dose once off all prednisone, as the split-dose regimen was likely implemented specifically for the twice-daily steroid dosing 3

Hypoglycemia risk:

  • The greatest risk period is the first 3-5 days after discontinuing evening prednisone
  • Ensure the patient has glucose monitoring capability and understands hypoglycemia symptoms
  • Consider prescribing glucagon for emergency use 3

Related Questions

For a type 2 diabetic patient taking prednisone 15 mg each morning (evening dose stopped) who was on insulin glargine (Lantus) 10 U in the morning and 10 U in the evening with an insulin‑to‑carbohydrate ratio of 1 U per 10 g carbs, what should the evening Lantus dose and the insulin‑to‑carbohydrate ratio be now?
For a patient with type 2 diabetes who is taking prednisone 15 mg in the morning and 10 mg in the evening, insulin glargine (Lantus) 10 units twice daily, and an insulin‑to‑carbohydrate ratio of 1 unit per 10 g carbohydrate, if the evening prednisone dose is reduced to 5 mg while the morning dose remains 15 mg, what should the insulin glargine dose and the carbohydrate‑to‑insulin ratio be adjusted to?
What overnight glucose pattern and basal insulin dose adjustment are recommended for an adult female with type 2 diabetes, bedtime blood glucose 126 mg/dL after 12 units of Lantus (insulin glargine), prior bedtime glucose 168 mg/dL after 16 units, morning glucose 132 mg/dL, HbA1c 8 %, and a 1:50 AM glucose reading of 96 mg/dL?
For a patient with type 2 diabetes using insulin glargine (Lantus) 16 U daily and a rapid‑acting insulin dose of 1 U per 12 g carbohydrate, who is currently taking prednisone 15 mg in the morning and 5 mg in the evening but will switch to prednisone 15 mg only in the morning, how much should the insulin glargine dose be reduced?
A patient with type 2 diabetes on prednisone 40 mg at 8 am, NPH insulin 23 units (morning dose) and a carbohydrate‑to‑insulin ratio of 1 unit per 15 g carbohydrate, who consumed 132 g carbohydrate in the past 24 hours and has blood glucose readings of 246 mg/dL at 4 pm and 281 mg/dL at 8 pm, asks how the carbohydrate‑to‑insulin ratio and the NPH insulin dose should be increased.
According to the 2026 GOLD guidelines, what is the recommended management for an acute exacerbation of chronic obstructive pulmonary disease (COPD)?
In a 42-year-old man with left hip pain that began one week after a bicycle fall, with functional limitation, pain on passive hip movement and tenderness over the greater trochanter, what is the most likely diagnosis and what urgent imaging and initial management should be undertaken?
What is the optimal management strategy for rheumatoid arthritis in a young adult?
What congenital heart defects are commonly associated with dextrocardia?
What is the appropriate treatment for persistent vomiting in a patient with normal upper endoscopy and normal CT enterography?
How should D-dimer be used as an investigative tool for evaluating suspected venous thromboembolism?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.